scholarly article | Q13442814 |
P2093 | author name string | Xiao-Hua Zhang | |
Gui-Long Guo | |||
Xiao-Qu Hu | |||
Xian Shen | |||
Jie You | |||
Ka-Te Huang | |||
Guan-Li Huang | |||
Kai-Yan Yang | |||
P433 | issue | 3 | |
P304 | page(s) | 673-679 | |
P577 | publication date | 2009-03-01 | |
P1433 | published in | Oncology Reports | Q7092098 |
P1476 | title | Clinical significance of miR-21 expression in breast cancer: SYBR-Green I-based real-time RT-PCR study of invasive ductal carcinoma | |
P478 | volume | 21 |
Q34252646 | A new strategy for identification of highly conserved microRNAs in non-model insect, Spodoptera litura |
Q37022250 | Androgens downregulate miR-21 expression in breast cancer cells underlining the protective role of androgen receptor |
Q52560790 | Circulating MicroRNA-21 Expression as a Novel Serum Biomarker for Oral Sub-Mucous Fibrosis and Oral Squamous Cell Carcinoma |
Q37413603 | Clinical significance of serum miR-21 in breast cancer compared with CA153 and CEA |
Q37378012 | Current molecular diagnostics of breast cancer and the potential incorporation of microRNA |
Q36057142 | Diagnostic, prognostic and predictive value of MicroRNA-21 in breast cancer patients, their daughters and healthy individuals. |
Q87401555 | Differential expression of miR-139, miR-486 and miR-21 in breast cancer patients sub-classified according to lymph node status |
Q36110374 | Expression of miR-21, miR-31, miR-96 and miR-135b is correlated with the clinical parameters of colorectal cancer |
Q42658857 | Fluorescence-coded DNA Nanostructure Probe System to Enable Discrimination of Tumor Heterogeneity via a Screening of Dual Intracellular microRNA Signatures in situ |
Q35105646 | High expression of miR-214 is associated with a worse disease-specific survival of the triple-negative breast cancer patients. |
Q54356219 | Higher miR-21 expression in invasive breast carcinomas is associated with positive estrogen and progesterone receptor status in patients from Serbia. |
Q36946688 | Inhibition of breast cancer cell motility with a non-cyclooxygenase inhibitory derivative of sulindac by suppressing TGFβ/miR-21 signaling |
Q34036642 | Long-range massively parallel mate pair sequencing detects distinct mutations and similar patterns of structural mutability in two breast cancer cell lines |
Q37764166 | Micro-RNAs and breast cancer |
Q36816367 | MicroRNA and cancer chemoprevention |
Q38070646 | MicroRNA-21 gene and cancer |
Q38163908 | MicroRNA-21 in breast cancer: diagnostic and prognostic potential |
Q39407479 | MicroRNA-223 functions as an oncogene in human gastric cancer by targeting FBXW7/hCdc4. |
Q86748477 | MicroRNA: A New Player for Cancer Chemoprevention |
Q33585094 | MicroRNAs in pathogenesis of breast cancer: Implications in diagnosis and treatment |
Q38034670 | New NSAID targets and derivatives for colorectal cancer chemoprevention. |
Q90376926 | Overview upon miR-21 in lung cancer: focus on NSCLC |
Q39529523 | Pilot Study of Serum MicroRNA-21 as a Diagnostic and Prognostic Biomarker in Egyptian Breast Cancer Patients |
Q35713817 | Prognostic Implications of MicroRNA-21 Overexpression in Invasive Ductal Carcinomas of the Breast |
Q36095156 | Role of TM4SF1 in regulating breast cancer cell migration and apoptosis through PI3K/AKT/mTOR pathway |
Q36677690 | Role of microRNAs in breast cancer |
Q36317309 | Serum miR-21 level: a potential diagnostic and prognostic biomarker for non-small cell lung cancer |
Q36024500 | Sulindac inhibits tumor cell invasion by suppressing NF-κB-mediated transcription of microRNAs |
Q37506648 | The PTEN-AKT3 signaling cascade as a therapeutic target in melanoma |
Q39258051 | The difference in miR-21 expression levels between invasive and non-invasive breast cancers emphasizes its role in breast cancer invasion |
Q51416072 | The mechanism study of lentiviral vector carrying methioninase enhances the sensitivity of drug-resistant gastric cancer cells to Cisplatin. |
Q36396579 | The role of microRNAs in breast cancer migration, invasion and metastasis |
Q47104938 | The roles of ncRNAs in the diagnosis, prognosis and clinicopathological features of breast cancer: a systematic review and meta-analysis |
Q47701015 | Therapeutic impacts of microRNAs in breast cancer by their roles in regulating processes involved in this disease |
Q92711379 | Transregulation of microRNA miR-21 promoter by AP-1 transcription factor in cervical cancer cells |
Q34575190 | miR-21 Expression in Pregnancy-Associated Breast Cancer: A Possible Marker of Poor Prognosis |
Q38739495 | miR-21 Might be Involved in Breast Cancer Promotion and Invasion Rather than in Initial Events of Breast Cancer Development. |
Q92665798 | miRNAs and Long-term Breast Cancer Survival: Evidence from the WHEL Study |
Q36224336 | microRNA expression pattern and its alteration following celecoxib intervention in human colorectal cancer |
Q37760459 | microRNAs and EMT in mammary cells and breast cancer. |
Q35185340 | microRNAs, Gap Junctional Intercellular Communication and Mesenchymal Stem Cells in Breast Cancer Metastasis |